Promotora Outreach for Cervical Cancer Screening

促进癌症研究的伙伴关系：NMSU & FHCRC（1/2） 试点项目#5：Promotora推广宫颈癌筛查 Hugo Vilchis（NMSU）/ Beti Thompson（FHCRC） 摘要 摘要 维基百科目前还没有名为“美国国家图书馆”的条目。宫颈癌的发病率几乎是 非西班牙裔白人的经历。这个问题在美国边境社区尤为严重。 和墨西哥巴氏试验用于早期宫颈病变检测的流行率差异如下： 我认为，在一定程度上解释了发病率的差异，然而，参与随访护理的差异 宫颈细胞学检查异常的妇女也可能导致这种差异。总目标 这一外展项目的主要目的是增加巴氏涂片检查和对巴氏涂片异常的后续检查， 生活在新墨西哥州和墨西哥边境社区的妇女。具体来说，使用启动程序 为推广巴氏测试及跟进异常测试，我们会： 1.首先，增加在特定边境社区诊所进行的巴氏试验的数量， 两间非干预诊所;以及 2.其次，提高特定边境诊所对异常巴氏涂片的随访率。 与干预诊所合作的Promotoras将接受培训，以提供信息并鼓励 妇女接受巴氏试验。他们还将接受培训，与诊所合作，以确定测试结果 并鼓励化验结果不正常的妇女接受跟进化验。最后，他们将妇女介绍给 如果初始或后续测试为阴性，则进行常规护理，或者如果女性出现以下症状，则将女性转介至治疗 宫颈癌社区中有许多机构治疗宫颈癌妇女。主要 与我们的具体目标相对应的感兴趣的问题是：1）。是否有增加巴氏试验的结果， 干预？和2）。是否增加了后续测试（例如，重复pap或阴道镜检查）作为结果， 干预？次要目的是回答问题3）：宫颈癌的治疗模式是什么？ 癌症吗在这个为期三年的项目的前六个月，信息将收集现有的巴氏试验， 三家诊所将参与其中。接下来的24个月将在一个诊所进行干预， 提高纸上检查率和对异常检查的跟踪率，并遵循治疗模式。期间 最后6个月，我们将评估pap筛查和异常pap随访率的差异。

Partnership for the Advancement of Cancer Research: NMSU & FHCRC (1 of 2) Pilot Project #5: Promotora outreach for cervical cancer screening Hugo Vilchis (NMSU) / Beti Thompson (FHCRC) ABSTRACT ABSTRACT Hispanic women in the United States (U.S.) experience nearly double the incidence of invasive cervical cancer experienced by non-Hispanic whites. The problem is especially severe in the border communities of the U.S. and Mexico. Differences in prevalence of Papanicolaou (Pap) tests for early cervical lesion detection are thought, in part, to explain the differences in incidence, however, difference in participation in follow-up care among women with abnormal cervical cytologic findings also may contribute to the disparity. The overall goals of this outreach project are to increase pap testing and follow-up testing for abnormal pap smears among women living in the border communities of New Mexico and Mexico. Specifically, using a promotora program to promote pap testing and follow-up for abnormal tests, we will: 1. Primarily, increase the number of pap tests that occur in a specific border community clinic compared to two non-intervention clinics; and 2. Secondarily, increase the follow-up rates for abnormal pap smears in the specific Border clinic. Promotoras who work with the intervention clinic will be trained to provide information to and encourage women to receive pap testing. They also will be trained to work with the clinic to identify the results of the tests and to encourage women with abnormal tests to receive follow-up testing. Finally, they will refer women to usual care if the initial or follow-up tests are negative or refer women to treatment if the woman presents with cervical cancer. A number of agencies exist in the community to treat women with cervical cancer. The main questions of interest, corresponding to our specific aims are: 1). Is there increased pap testing as a result of the intervention? and 2). Is there increased follow-up testing (e.g., repeat pap or colposcopy) as a result of the intervention? A secondary aim is to answer question 3): What is the pattern(s) for treatment of cervical cancer? During the first six months of this three year project, information will be gathered on existing pap test rates in the three clinics that will participate. The next 24 months will consist of intervention in one clinic to increase pap screening rates and follow-up rates for abnormal tests and to follow treatment patterns. During the final 6 months, we will assess differences in pap screening and abnorma pap follow-up rates.